AEON Biopharma, Inc.
AEON · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $42,005 | -$384,632 | -$52,556 | -$55,637 |
| Dep. & Amort. | $97 | $99 | $68 | $3 |
| Deferred Tax | $0 | $0 | $4,747 | $1,183 |
| Stock-Based Comp. | $6,250 | $0 | $5,892 | $5,220 |
| Change in WC | $706 | -$2,739 | $6,268 | $1,416 |
| Other Non-Cash | -$69,350 | $339,447 | -$3 | $19,382 |
| Operating Cash Flow | -$20,292 | -$47,825 | -$35,584 | -$28,433 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$306 | -$170 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$306 | -$170 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $15,000 | $14,000 | $40,508 | $15,000 |
| Stock Issued | $147 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$1,437 |
| Financing Cash Flow | $15,147 | $14,000 | $40,508 | $13,563 |
| Forex Effect | $0 | $29,237 | $0 | $0 |
| Net Chg. in Cash | -$5,145 | -$4,588 | $4,618 | -$15,040 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,158 | $9,746 | $5,128 | $20,168 |
| End Cash | $13 | $5,158 | $9,746 | $5,128 |
| Free Cash Flow | -$20,292 | -$47,825 | -$35,890 | -$28,603 |